AstraZeneca Pharma India, a company in the Pharmaceuticals industry, reported revenue of ₹729 crore and net profit of ₹62 crore for the September 2026 quarter.
AstraZeneca Pharma India (NSE: ASTRAZEN) closed at ₹6,167.50 on 20 Nov 2026, down 32.5% over the past year. Its market capitalisation is ₹15,419 crore and it trades at 81.9 times earnings.
AstraZeneca Pharma India Ltd is engaged in the business of manufacture, distribution and marketing of pharmaceutical products.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.